Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial-Reference-Cited by-同舟云学术

Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial

Published:2005-09 Issue:5 Volume:58 Page:424-428
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Coric Vladimir,Taskiran Sarper,Pittenger Christopher,Wasylink Suzanne,Mathalon Daniel H.,Valentine Gerald,Saksa John,Wu Yu-te,Gueorguieva Ralitza,Sanacora Gerard,Malison Robert T.,Krystal John H.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference24 articles.

1. Treatment of obsessive–compulsive disorder in patients who have comorbid major depression;Abramowitz;J Clin Psychol,2004

2. Reduced glutamate in the anterior cingulate cortex in depression;Auer;Biol Psychiatry,2000

3. Rilutek;Aventis,2004

4. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive–compulsive disorder and major depressive disorder;Coric;Psychopharmacology,2003

5. Functional imaging of brain systems mediating obsessive–compulsive disorder;Baxter,2001

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders;Psikiyatride Güncel Yaklaşımlar;2024-09-30

2. New horizons for obsessive-compulsive disorder drug discovery: is targeting glutamate receptors the answer?;Expert Opinion on Drug Discovery;2024-08-06

3. Pharmakotherapie;S3-Leitlinie Zwangsstörungen;2024

4. The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia;Biomolecules;2023-08-05

5. Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review;Neuropsychopharmacology Reports;2023-07-18